Drug General Information (ID: DDI9E5M8YJ)
Drug Name			Cyclosporine		Drug Info		Amphotericin B (cholesteryl sulfate)		Drug Info
Drug Type		Small molecule				Small molecule
Therapeutic Class		Antiviral Agents				Antifungal Agents
Structure

Mechanism of Cyclosporine-Amphotericin B (cholesteryl sulfate) Interaction (Severity Level: Moderate)
Increased risk of nephrotoxicity Click to Show/Hide Mechanism Graph
Drug Name		Cyclosporine				Amphotericin B (cholesteryl sulfate)
Mechanism		Nephrotoxicity				Nephrotoxicity
Key Mechanism Factor 1
		Factor Name		Nephrotoxicity
		Factor Description		The combination of drugs that can induce nephrotoxicity may increase the risk of kidney injury. When kidney injury occurs, the inability to remove excess urine and waste from the body can lead to high levels of urea nitrogen, creatinine, and electrolytes (such as potassium and magnesium) in the blood.
Mechanism Description		Increased risk of nephrotoxicity by the combination of Cyclosporine and Amphotericin B (cholesteryl sulfate)

Recommended Action
Management		Alternate antifungal therapy is recommended. If these agents must be used concomitantly, renal function should be closely monitored.

References
1	Cockburn IT, Krupp P "An appraisal of drug interactions with sandimmun." Transplant Proc 21 (1989): 3845-50. [PMID: 2683269]
2	Kennedy M, Deeg J, Siegel M, et al "Acute renal toxicity with combined use of amphotericin B and cyclosporine after marrow transplantation." Transplantation 35 (1983): 211-5. [PMID: 6340275]
3	Product Information. Sandimmune (cyclosporine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.